Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Cumulative evidence indicates that mitochondrial dysfunction has a role in heart failure progression, but whether mitochondrial quality control mechanisms are involved in the development of cardiac dysfunction remains unclear. Here we show that cytosolic p53 impairs autophagic degradation of damaged mitochondria and facilitates mitochondrial dysfunction and heart failure in mice. Prevalence and induction of mitochondrial autophagy is attenuated by senescence or doxorubicin treatment in vitro and in vivo. We show that cytosolic p53 binds to Parkin and disturbs its translocation to damaged mitochondria and their subsequent clearance by mitophagy. p53-deficient mice show less decline of mitochondrial integrity and cardiac functional reserve with increasing age or after treatment with doxorubicin. Furthermore, overexpression of Parkin ameliorates the functional decline in aged hearts, and is accompanied by decreased senescence-associated β-galactosidase activity and proinflammatory phenotypes. Thus, p53-mediated inhibition of mitophagy modulates cardiac dysfunction, raising the possibility that therapeutic activation of mitophagy by inhibiting cytosolic p53 may ameliorate heart failure and symptoms of cardiac ageing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Defective mitophagy has also been linked with premature aging and many age-associated disorders, such as Alzheimer’s and Parkinson’s diseases (25–28).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study has shown that increased p53 cytosolic localization prevents Parkin translocation to mitochondria during organismal aging (27).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“| Cardiomyopathies | Whole‐body deletion of Tp53 | Decelerated cardiac aging, linked to improved mitophagic responses after stabilization of PRKN | Hoshino et al (2013) |”
From Autophagy in major human diseases (2021) · cites this paper as Hoshino et al (2013)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Cited by
Items 201–300 of 533
Therapeutic opportunities for senolysis in cardiovascular disease
Sweeney, M., Cook, S. A., & Gil, J. (2022) · FEBS Journal · doi:10.1111/febs.16351 · Cited by 56
Chemotherapy impairs skeletal muscle mitochondrial homeostasis in early breast cancer patients
Mallard, J., Hucteau, E., Charles, A., Bender, L., Baeza, C., Pélissié, M., Trensz, P., Pflumio, C., Kalish‐Weindling, M., Gény, B., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12991 · Cited by 55
“Parkin and disturbs its translocation, leading to a reduced mitophagy, and promoting the accumulation of damaged mitochondria.(39,40) These two hypotheses contradict each other and reflect the need to better understand mitochondrial dynamics and mitophagy in breast cancer patients.”
BackgroundMolecular mechanisms and clinical implications of multiple forms of mitophagy in the heart
Saito, T., Hamano, K., & Sadoshima, J. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa340 · Cited by 51
Zhou, Z., Wang, J., Song, Y., He, Y., Zhang, C., Liu, C., Zhao, H., Dun, Y., Yuan, D., & Wang, T. (2017) · Phytotherapy Research · doi:10.1002/ptr.5961 · Cited by 51
“Mitochondrial dysfunction has been widely correlated with age‐related cardiac diseases; impaired mitochondria as an early event in HF has become a feature of cardiac aging (Hoshino et al., 2013; Karamanlidis, Bautista‐Hernandez, Fynn‐Thompson, Del Nido, & Tian, 2011).”
BackgroundProtein and Mitochondria Quality Control Mechanisms and Cardiac Aging
Ghosh, R., Vinod, V., Symons, J. D., & Boudina, S. (2020) · Cells · doi:10.3390/cells9040933 · Cited by 53
“PINK1 mutations are a dominant feature of age-related diseases including Parkinson’s and PARKIN deficiency is associated with distorted mitochondrial morphology, enhanced mitochondrial DNA mutation rate, and premature cardiac aging [67].”
BackgroundMitochondrial quality surveillance: mitophagy in cardiovascular health and disease
Diao, R. Y., & Gustafsson, Å. B. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00360.2021 · Cited by 54
Mitophagy and Mitochondrial Quality Control Mechanisms in the Heart
Gottlieb, R. A., & Thomas, A. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0133-y · Cited by 50
Mitophagy in cardiovascular disease
Zhou, H., He, L., Xu, G., & Chen, L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.033 · Cited by 50
Gao, B., Yu, W., Lv, P., Liang, X., Sun, S., & Zhang, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165997 · Cited by 53
Impaired dynamics and function of mitochondria caused by mtDNA toxicity leads to heart failure
Lauritzen, K. H., Kleppa, L., Aronsen, J. M., Eide, L., Carlsen, H., Haugen, Ø. P., Sjaastad, I., Klungland, A., Rasmussen, L. J., Attramadal, H., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00253.2014 · Cited by 47
“636 It has recently been shown that mitochondrial dysfunction triggers a p53-mediated response 637 that regulates mitophagy and that this response is crucial to prevent heart failure in mice (20).”
BackgroundTriggering of Parkin Mitochondrial Translocation in Mitophagy: Implications for Liver Diseases
Eid, N. A. S., Ito, Y., & Otsuki, Y. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00100 · Cited by 47
“Meanwhile, it has also been found that Parkin mitochondrial translocation may be repressed by cytoplasmic P53, thus preventing mitophagy induction in the myocardial muscle of stressed mice (Hoshino et al., 2013).”
BackgroundMechanisms driving the ageing heart
Anderson, R., Richardson, G. D., & Passos, J. F. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.015 · Cited by 46
Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
Liang, Z., He, Y., & Hu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810617 · Cited by 49
“Mice lacking P53 show relatively weak inhibition of mitochondrial autophagy after DOX intervention [41].”
BackgroundWang, Y., Xu, Y., Guo, W., Fang, Y., Hu, L., Wang, R., Zhao, R., Guo, D. S., Qi, B., Ren, G., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102537 · Cited by 49
“regulation of Parkin was reported in the hearts of aged mice [57], whereas overexpression of Parkin alleviated functional decline in aged hearts [18].”
BackgroundDisruption of the Keap1/Nrf2-Antioxidant Response System After Chronic Doxorubicin Exposure In Vivo
Nordgren, K. K. S., & Wallace, K. B. (2020) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09581-7 · Cited by 47
“Evidence has suggested the p53 may function to competitively recruit Parkin away from PINK1 [35].”
BackgroundChen, Q., Thompson, J., Hu, Y., & Lesnefsky, E. J. (2021) · Aging · doi:10.18632/aging.202858 · Cited by 46
“Contributing mechanisms of mitochondrial dysfunction with age include oxidative modifications and deletions in mitochondrial DNA [18], oxidative modification of proteins [19], activation of mitochondrial proteases [20], the impaired removal of damaged mitochondria via mitophagy [21, 22] and an increase in endoplasmic…”
BackgroundKanglexin delays heart aging by promoting mitophagy
Li, H., Liu, X., Meng, Z., Wang, L., Zhao, L., Chen, H., Wang, Z.-X., Cui, H. Z., Tang, X., Li, X., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00686-5 · Cited by 47
Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease
Hruby, A. J., & Higuchi‐Sanabria, R. (2025) · npj Aging · doi:10.1038/s41514-025-00291-4 · Cited by 63
“…of mitochondrial fi ssion and promotion of mitochondrial elongation, which decreases ΔΨ m, and increases ROS production 395,396 . p53 also binds to Parkin to prevent its translocation to damaged mitochondria, inhibiting mitophagy, decreasing ΔΨ m, and increasing ROS production 106,397,398 .”
The beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy
Marques‐Aleixo, I., Alves, E. S., Oliveira, P. J., Moreira, P. I., Magalhães, J., & Ascensão, A. A. M. R. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.01.002 · Cited by 47
p53-mediated activation of the mitochondrial protease HtrA2/Omi prevents cell invasion
Yamauchi, S., Hou, Y., Guo, A. K., Hirata, H., Nakajima, W., Yip, A. K., Yu, C., Harada, I., Chiam, K., Sawada, Y., et al. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201309107 · Cited by 46
“Because immortal cells have genes with mutations, this may influence the cleavage of -actin in response to oncogenic Ras. mitochondria (Hoshino et al., 2013) and may facilitate the accumulation of mitochondria with low m in Ras-transformed cells.”
Sen, B., Rastogi, A., Nath, R., Shasthry, S. M., Pamecha, V., Pandey, S., Gupta, K. J., Sarin, S. K., Trehanpati, N., & Ramakrishna, G. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.03.001 · Cited by 47
“Dysfunctional mitochondria are removed by the process of mitophagy, which is often defective in senescence.(12) Defective mitophagy has been well studied in the context of liver disease.”
BackgroundCardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy
Nishi, M., Wang, P., & Hwang, P. M. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316697 · Cited by 53
Association of p53 with Neurodegeneration in Parkinson’s Disease
Luo, Q., Sun, W., Wang, Y., Li, J., & Li, D.-W. (2022) · Parkinson s Disease · doi:10.1155/2022/6600944 · Cited by 49
“…while depletion of endogenous p53 promotes its expression and mRNA levels, supporting p53 as a transcriptional inhibitor of PINK1 transcription [9]. p53 also directly interacts with Parkin to inhibit its translocation to the damaged mitochondria, resulting in the impairment of mitophagy [126].”
Ling, G., Wang, X., Tan, N., Cao, J., Li, W., Zhang, Y., Jiang, J., Sun, Q., Jiang, Y., Wang, W., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7176282 · Cited by 47
“In addition, DOX upregulates the expression of the p53 gene, which binds to the Parkin and inhibits the autophagy clearance of the damaged mitochondria, resulting in mitochondrial biological energy depletion [102].”
BackgroundCardiovascular aging: from cellular and molecular changes to therapeutic interventions
Vakka, A., Warren, J. S., & Drosatos, K. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.09 · Cited by 70
“Inhibition of Parkin mitochondrial translocation -via p53- in the hearts of aged mice impairs mitophagy and causes cardiac dysfunction[78].”
BackgroundRedd1 knockdown prevents doxorubicin-induced cardiac senescence
Huang, P., Bai, L., Liu, L., Fu, J. F., Wu, K., Liu, H., Liu, Y., Qi, B., & Qi, B. (2021) · Aging · doi:10.18632/aging.202972 · Cited by 47
“In the Dox-induced cardiomyocyte senescence model, Dox (D1515, Sigma-Aldrich, St. Louis, MO) was administered intraperitoneally via six injections (each containing 2.5 mg/kg Dox) over a AGING period of 2 weeks, to reach a total cumulative dosage of 15 mg/kg [65, 66].”
InfluentialMetabolic Complications in Cardiac Aging
Thomas, S., & Drosatos, K. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.669497 · Cited by 48
Lin, S., Wang, Y., Zhang, X., Kong, Q., Li, C., Li, Y., Ding, Z., & Liu, L. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2586706 · Cited by 43
“Moreover, p53 inhibits Parkin-mediated mitophagy [45].”
Svaguša, T., Martinić, M., Martinić, M., Kovačević, L., Šepac, A., Miličić, D., Bulum, J., Starčević, B., Sirotković-Skerlev, M., Seiwerth, F., et al. (2020) · Croatian Medical Journal · doi:10.3325/cmj.2020.61.126 · Cited by 44
Hu, D., Cao, S., Zhang, G., Xiao, Y., Liu, S., & Shang, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-13860-9 · Cited by 46
Zheng, R., Yao, Q., Xie, G., Du, S., Ren, C., Wang, Y., & Yuan, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.4002 · Cited by 41
“It was reported that p53 promotes mitochondrial dysfunction by inhibiting Parkin-mediated mitophagy in mouse heart cells and pancreatic β-cells [17, 18].”
The Crosstalk between ROS and Autophagy in the Field of Transplantation Medicine
van Erp, A. C., Hoeksma, D., Rebolledo, R. A., Ottens, P. J., Jochmans, I., Monbaliu, D. R. L., Pirenne, J., Leuvenink, H. G. D., & Decuypere, J.-P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7120962 · Cited by 47
“The link between ROS and mitophagy was confirmed in a study on heart failure in mice, describing that p53-induced impairment of mitophagy resulted in mitochondrial dysfunction and increased ROS production [76, 77].”
BackgroundHeart Failure as an Aging-Related Phenotype: Wnt/β-Catenin Signaling and p53 Pathway
Morita, H., & Komuro, I. (2018) · International Heart Journal · doi:10.1536/ihj.17-519 · Cited by 45
Mitochondrial Control of Genomic Instability in Cancer
Bonora, M., Missiroli, S., Perrone, M., Fiorica, F., Pinton, P., & Giorgi, C. (2021) · Cancers · doi:10.3390/cancers13081914 · Cited by 46
“In particular, nuclear p53 suppresses the expression of PINK1 [37] while cytoplasmic p53 interacts with Parkin, interfering with its translocation to mitochondria [38], then favoring the accumulation of dysfunctional mitochondria prone to engage MOMP.”
BackgroundGuo, Y., Tang, Y., Lu, G., & Gu, J. (2023) · Nutrients · doi:10.3390/nu15102259 · Cited by 42
“The binding of cytoplasmic p53 to Parkin in DIC impairs the autophagic degradation of damaged mitochondria by inhibiting its mitochondrial transport [33].”
BackgroundAutophagy-related proteins: Potential diagnostic and prognostic biomarkers of aging-related diseases
Miceli, C., Leri, M., Stefani, M., & Bucciantini, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101967 · Cited by 41
p53 contributes to cardiovascular diseases via mitochondria dysfunction: A new paradigm
Wang, H., Yu, W., Wang, Y., Wu, R., Dai, Y., Deng, Y., Wang, S., Yuan, J., & Tan, R. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.09.036 · Cited by 42
Effect of p53 on mitochondrial morphology, import, and assembly in skeletal muscle
Saleem, A., Iqbal, S., Zhang, Y., & Hood, D. A. (2015) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00253.2014 · Cited by 40
MiRNA Deregulation in Cardiac Aging and Associated Disorders
Verjans, R., van Bilsen, M., & Schroen, B. L. M. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.004 · Cited by 42
Infiltrating macrophages amplify doxorubicin-induced cardiac damage: role of catecholamines
Gambardella, J., Santulli, G., Fiordelisi, A., Cerasuolo, F. A., Wang, X., Prevete, N., Sommella, E., Avvisato, R., Buonaiuto, A., Altobelli, G. G., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04922-5 · Cited by 41
Moments in autophagy and disease: Past and present
Wen, X., Yang, Y., & Klionsky, D. J. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100966 · Cited by 40
FOXO3a-dependent PARKIN negatively regulates cardiac hypertrophy by restoring mitophagy
Sun, T., Han, Y., Li, J., Jiao, X., Zuo, L., Wang, J., Yang, J., Yang, J.-L., Cao, J.-M., & Wang, J. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00935-y · Cited by 44
p53 at the crossroad between mitochondrial reactive oxygen species and necroptosis
Rius‐Pérez, S. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.022 · Cited by 40
New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases
Disatnik, M., Hwang, S., Ferreira, J. C. B., & Mochly‐Rosen, D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1256-4 · Cited by 37
The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction
Dolinsky, V. W. (2017) · Biological Chemistry · doi:10.1515/hsz-2016-0316 · Cited by 38
Casieri, V., Matteucci, M., Cavallini, C., Torti, M., Torelli, M., & Lionetti, V. (2017) · Scientific Reports · doi:10.1038/s41598-017-13949-1 · Cited by 38
The Tumor Suppressor, P53, Decreases the Metal Transporter, ZIP14
Zhao, N., Zhang, A., Wortham, A. M., Jue, S. F., Knutson, M. D., & Enns, C. A. (2017) · Nutrients · doi:10.3390/nu9121335 · Cited by 40
“It also possesses transcription-independent cytosolic functions, including inhibition of autophagy [6–9], regulation of mitochondrial function [10,11] and regulation of apoptosis [12].”
BackgroundLi, Y., Liu, Z., Zhang, Y., Zhao, Q., Wang, X., Lü, P., Zhang, H., Wang, Z., Dong, H., & Zhang, Z. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3536 · Cited by 39
“Recent studies have suggested that mitophagy plays a specific role in eliciting cardioprotective benefits by removing damaged mitochondria (12,13).”
BackgroundAutophagy and cancer therapy cardiotoxicity: From molecular mechanisms to therapeutic opportunities
Li, M., Russo, M., Pirozzi, F., Tocchetti, C. G., & Ghigo, A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.06.007 · Cited by 39
Mitochondrial function, dynamics and quality control in the pathophysiology of HFpEF
del Campo, A., Perez, G., Castro, P., Parra, V., & Verdejo, H. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166208 · Cited by 41
Deng, Z., Yao, J., Xiao, N., Yu, H., Wu, X., Ci, C., Chen, K., & Geng, X. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00740-8 · Cited by 40
Recent progress in research on molecular mechanisms of autophagy in the heart
Maejima, Y., Chen, Y., Isobe, M., Gustafsson, Å. B., Kitsis, R. N., & Sadoshima, J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00711.2014 · Cited by 39
Intimate Relations—Mitochondria and Ageing
Webb, M., & Sideris, D. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207580 · Cited by 38
“In addition to the contribution of dysfunctional mitochondria to neurodegeneration, mitochondria with decreased membrane potential was also observed in aged skeletal muscle satellite cells isolated from humans or mice, as well as increased mitochondrial accumulation inside autophagosomes indicative of inefficient mito…”
BackgroundHarpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy
Li, W., Wang, X., Liu, T., Zhang, Q., Cao, J., Jiang, Y., Sun, Q., Li, C., Wang, W., & Wang, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.813370 · Cited by 36
“, 2011), which may disturb the clearance of damaged mitochondria via an inhibitory interaction with Parkin, and subsequently blocks Parkin translocation to the mitochondria and subsequent mitophagy (Hoshino et al., 2013), finally leading to DICT.”
BackgroundInfluentialMitochondrial Bioenergetics and Dynamism in the Failing Heart
Morciano, G., Vitto, V. A. M., Bouhamida, E., Giorgi, C., & Pinton, P. (2021) · Life · doi:10.3390/life11050436 · Cited by 42
“From these findings, it is clear that mitophagy is a critical mitochondrial quality con-trol mechanism in myocytes [140–142].”
BackgroundMitochondrial Quality Control: the Role in Cardiac Injury
Sygitowicz, G., & Sitkiewicz, D. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2703096 · Cited by 38
Mitophagy imbalance in cardiomyocyte ischaemia/reperfusion injury
Li, Y., Wu, X., Liu, X., & Li, P. (2018) · Acta Physiologica · doi:10.1111/apha.13228 · Cited by 36
“Cytosolic p53 binds to Parkin and disturbs its translocation to damaged mitochondria and their subsequent clearance by mitophagy in hearts.(56) Mst1 is a core component of Hippo pathway.”
BackgroundYamashita, A., Matsuoka, Y., Matsuda, M., Kawai, K., Sawa, T., & Amaya, F. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.07.045 · Cited by 33
Mitochondrial Quality Control in the Heart: New Drug Targets for Cardiovascular Disease
Oh, C., Ryu, D., Cho, S., & Jang, Y. (2020) · Korean Circulation Journal · doi:10.4070/kcj.2019.0416 · Cited by 34
Mitophagy in Parkinson's disease: From pathogenesis to treatment target
Dernie, F. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104756 · Cited by 34
Common Principles and Specific Mechanisms of Mitophagy from Yeast to Humans
Kumar, R., & Reichert, A. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094363 · Cited by 36
“Thus, genetic and pharmacological inhibition of p53 can activate PARKIN-dependent mitophagy, preserving mitochondrial integrity and protecting against glucose tolerance, heart failure, and cardiac aging in mice [97,98].”
BackgroundDual Role of Mitophagy in Cardiovascular Diseases
Li, Y., Meng, W., Hou, Y., Li, D., Wang, X., Wu, K., Sun, S., Liu, H., Li, X., Lin, F., et al. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001046 · Cited by 36
Huang, W., Xie, W., Zhong, H., Cai, S., Huang, Q., Liu, Y., Zeng, Z., & Liu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859231 · Cited by 42
“The direct molecular link between p53 activation and Parkin-mediated mitophagy deficiency contributes to the mitochondrial compromise associated with aging-related and doxorubicin (DOX)mediated decreases in cardiac contractility (47).”
BackgroundLoss of Parkin reduces inflammatory arthritis by inhibiting p53 degradation
Jung, Y. Y., Son, D. J., Lee, H. L., Kim, D. H., Song, M. J., Ham, Y. W., Kim, Y., Han, S., Park, M. H., & Hong, J. T. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.007 · Cited by 33
Cardiac Specific Knockout of p53 Decreases ER Stress-Induced Mitochondrial Damage
Chen, Q., Thompson, J., Hu, Y., Das, A., & Lesnefsky, E. J. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00010 · Cited by 33
“p53 is a tumor suppressor protein that regulates cell cycle and DNA repair pathways (22, 23).”
BackgroundMitophagy impairment in neurodegenerative diseases: Pathogenesis and therapeutic interventions
Mani, S., Swargiary, G., & Chadha, R. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.001 · Cited by 33
Ma, X., Rawnsley, D. R., Kovács, A. D., Islam, M., Murphy, J. T., Zhao, C., Kumari, M., Foroughi, L., Liu, H., Qi, K., et al. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.12.002 · Cited by 33
Ohira, S., Tanaka, H., Harada, Y., Minamikawa, T., Kumamoto, Y., Matoba, S., Yaku, H., & Takamatsu, T. (2017) · Scientific Reports · doi:10.1038/srep42401 · Cited by 32
“The sequential state IV and state III oxygen consumption rate of the isolated mitochondria (750 μ g) of the rat heart was monitored with a fiber-optic system 27 .”
Self-citationMitochondrial quality control in the cardiac system: An integrative view
Cadete, V. J. J., Vasam, G., Menzies, K. J., & Burelle, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.018 · Cited by 39
Mdm2 enhances ligase activity of parkin and facilitates mitophagy
Kook, S., Zhan, X., Thibeault, K. C., Ahmed, M. R., Gurevich, V. V., & Gurevich, E. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-61796-4 · Cited by 34
Mitophagy in cardiovascular homeostasis
Zhang, R., Krigman, J., Luo, H., Ozgen, S., Yang, M., & Sun, N. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111245 · Cited by 36
“In aged hearts, overexpression of Parkin ameliorates the cardiac functional decline with more mitochondria incorporated into autophagosomes (Hoshino et al., 2013).”
BackgroundMitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines
Milane, L. S., Dolare, S., Jahan, T., & Amiji, M. M. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102422 · Cited by 33
Regulation of p53 Function by Formation of Non-Nuclear Heterologous Protein Complexes
Zavileyskiy, L. G., & Bunik, V. I. (2022) · Biomolecules · doi:10.3390/biom12020327 · Cited by 31
“E3 ubiquitin-protein ligase parkin (O60260, gene PRKN) [63] n.”
BackgroundMultiple recycling routes: Canonical vs. non-canonical mitophagy in the heart
Moyzis, A. G., & Gustafsson, Å. B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.034 · Cited by 34
Human Rights Here and Now: Celebrating the Universal Declaration of Human Rights.
Flowers, N. B. (1998) · Cited by 82
Chen, Y., Huang, T., Shi, W., Fang, J., Deng, H., & Cui, G. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.150 · Cited by 33
Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies
Bertero, E., Kutschka, I., Maack, C., & Dudek, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165803 · Cited by 35
Enhanced mitophagy mediated by the YAP/Parkin pathway protects against DOX-induced cardiotoxicity
Xiao, D., Chang, W., Ding, W., Wang, Y., Fa, H., & Wang, J. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.05.015 · Cited by 31
Thompson, J., Maceyka, M. W., & Chen, Q. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111380 · Cited by 30
“Impaired mitophagy contributes to mitochondrial defects in aged hearts (Hoshino et al., 2013).”
BackgroundRelevance of endoplasmic reticulum and mitochondria interactions in age-associated diseases
Gil-Hernández, A., & Silva‐Palacios, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101193 · Cited by 31
Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy
Wilfinger, N., Austin, S., Scheiber‐Mojdehkar, B., Berger, W., Reipert, S., Praschberger, M., Paur, J., Trondl, R., Keppler, B. K., Zielinski, C. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6233 · Cited by 31
Pascucci, B., D’Errico, M., Romagnoli, A., Nuccio, C. D., Savino, M., Pietraforte, D., Lanzafame, M., Calcagnile, A. S., Fortini, P., Baccarini, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9913 · Cited by 32
“Finally, whether the hyperactivation of p53 that characterizes CS cells plays a role by directly interacting with DRP1 [27] or with other mitophagy partners [39] deserves to be explored.”
BackgroundMitophagy modulation for the treatment of cardiovascular diseases
Forte, M., D’Ambrosio, L., Schiattarella, G. G., Salerno, N., Perrone, M. A., Loffredo, F. S., Bertero, E., Pilichou, K., Manno, G., Valenti, V., et al. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14199 · Cited by 32
“16 The ubiquitin-specific protease 30 (Usp30) was found to accelerate cell senescence in cardiac cells in association with reduced activity of Parkin and mitophagy.”
BackgroundXia, D., Liu, Y., Wu, P., & Wei, D. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.06.013 · Cited by 34
Obesity is a common soil for premature cardiac aging and heart diseases - Role of autophagy
Sun, M., Tan, Y., Rexiati, M., Dong, M., & Guo, W. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.004 · Cited by 32
Liu, X., Zhang, S., An, L. K., Wu, J., Hu, X., Lai, S., Mazhar, H., Zou, Y., He, L., & Zhu, H. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.07.074 · Cited by 30
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity
Russo, M., Bono, E., & Ghigo, A. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00519-w · Cited by 28
Assessment of mitophagy in human iPSC-derived cardiomyocytes
Yang, M., Fu, J., Zou, J., Sridharan, D., Zhao, M., Singh, H., Krigman, J., Khan, M., Xin, G., & Sun, N. (2022) · Autophagy · doi:10.1080/15548627.2022.2037920 · Cited by 30
“Though several studies suggest doxorubicin induces cardiac mitophagy [58,59], there is increasing evidence to support either autophagy or mitophagy attenuation as a contributor to doxorubicin-induced cardiomyopathy [56,60,61].”
BackgroundLi, Y., Lin, R., Peng, X., Wang, X., Liu, X., Li, L., Bai, R., Wen, S., Ruan, Y., Chang, X., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3659278 · Cited by 29
“Knockdown of p53 or parkin overexpression was found to reverse this side e ff ect [129].”
Essandoh, K., Wang, X., Huang, W. C., Deng, S., Gardner, G., Mu, X., Li, Y., Kranias, E. G., Wang, Y., & Fan, G. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008925 · Cited by 29
“Previous work has demonstrated that increased levels of Parkin can protect against cardiac mitochondrial dysfunction and cardiac aging in 20-month-old mice (41).”
BackgroundDawi, J., Affa, S., Gonzalez, E., Misakyan, Y., Nikoghosyan, D., Hajjar, K., Kades, S., Fardeheb, S., Mirzoyan, H., & Venketaraman, V. (2024) · Biomedicines · doi:10.3390/biomedicines12030558 · Cited by 30
Herrer, I., Roselló‐Lletí, E., Ortega, A., Tarazón, E., Molina‐Navarro, M. M., Triviño, J. C., Martínez‐Dolz, L., Bonet, L. A., Lago, F., Sánchez-Lázaro, I. J., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0088-y · Cited by 33
“that cytosolic sequestration of p53 facilitates mitochondrial dysfunction and HF in mice [39].”
The role of toll-like receptors in myocardial toxicity induced by doxorubicin
Xinyong, C., Zhiyi, Z., Hong, L., Peng, Y., Xiao-Cheng, W., Ping, Z., & Shao, L. (2019) · Immunology Letters · doi:10.1016/j.imlet.2019.11.001 · Cited by 27
Ulk1/Rab9-mediated alternative mitophagy confers cardioprotection during energy stress
Dhingra, R., Rabinovich-Nikitin, I., & Kirshenbaum, L. A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125980 · Cited by 30
Parkin: a potential target to promote healthy ageing
Leduc‐Gaudet, J., Hussain, S. N. A., & Gouspillou, G. (2022) · The Journal of Physiology · doi:10.1113/jp282567 · Cited by 27
“…overexpression in old mice decreased the number of abnormal mitochondria, attenuated ageing-related decreases in mitochondrial respiration and enhanced reactive oxygen species (ROS) production and maintained cardiac functional reserve at levels similar to those of youngmice (Hoshino et al., 2013).”
BackgroundMicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
Kawano, I., & Adamcová, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1055911 · Cited by 26
“, 2019), and impaired mitophagy (Hoshino et al., 2013; Li et al., 2022) in cardiomyocytes, potentiating cell death.”
BackgroundSun, X., Chen, H., Gao, R., Huang, Y., Qu, Y., Yang, H., Wei, X., Hu, S., Zhang, J., Wang, P., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107790 · Cited by 33
“12 The mitochondrial damage induced by doxorubicin has also been shown to trigger autophagic and mitophagic responses 13 as well as the mitochondria-dependent apoptotic pathway.”
A Healthy Heart and a Healthy Brain: Looking at Mitophagy
Luo, H., Zhang, R., Krigman, J., McAdams, A., Ozgen, S., & Sun, N. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00294 · Cited by 25
C. elegans as an Animal Model to Study the Intersection of DNA Repair, Aging and Neurodegeneration
Naranjo-Galindo, F. J., Ai, R., Fang, E. F., Nilsen, H. L., & SenGupta, T. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.916118 · Cited by 31
“In humans and mice, mitophagy levels were shown to be lower in the hippocampus dentate gyrus, hearts, and skeletal muscle satellite cells (Hoshino et al., 2013; Sun et al., 2015; Bravo-San Pedro et al., 2017).”
BackgroundGuan, C., Zhang, H., Wang, Y., Chen, Z.-T., Deng, B., Qiu, Q., Chen, S., Wu, M., Chen, Y., & Wang, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5572088 · Cited by 25
Metadata
- Authors
- Hoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T., Ikeda, K., Ogata, T., & Matoba, S.
- Affiliations
- Kyoto Prefectural University (JP)
- Corresponding author
- Matoba, Satoaki
- Venue
- Nature Communications
- Published
- 2013-08-06
- Volume
- 4
- Issue
- 1
- Pages
- 2308-2308
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2030548258
- Cited by
- 536
- References
- 54
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 53 · 2023: 48 · 2022: 68 · 2021: 50 · 2020: 58 · 2019: 42 · 2018: 36 · 2017: 52 · 2016: 23 · 2015: 29 · 2014: 22 · 2013: 1
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Parkin, mitophagy, mitochondrial dysfunction, heart failure, cardiac aging, mitochondrial quality control, autophagy, cellular senescence, doxorubicin cardiotoxicity, cardiac dysfunction
- MeSH terms
- Aging, Animals, Cytosol, Doxorubicin, Embryo, Mammalian, Fibroblasts, Heterozygote, Humans, Mice, Transgenic, Mitochondria, Myocardium, Protein Binding, Tumor Suppressor Protein p53, Cellular Senescence, Protein Structure, Tertiary, Protein Transport, Ubiquitin-Protein Ligases, HCT116 Cells, Mice, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.